Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard L Haspel

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Archives of Pathology & Laboratory Medicine|July 1, 2010
Implementation and assessment of a resident curriculum in evidence-based transfusion medicineRichard L Haspel
Advances in Anatomic Pathology|February 13, 2013
Teaching residents genomic pathology: a novel approach for new technologyRichard L Haspel
Clinical Chemistry|July 7, 2020
Commentary on Sequence Now, Later, or Never?Richard L Haspel
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|March 24, 2005
The "cutting" edge: von Willebrand factor-cleaving protease activity in thrombotic microangiopathiesRichard L Haspel, Petr Jarolím
Hematology. American Society of Hematology. Education Program|December 17, 2008
Which patients with paroxysmal nocturnal hemoglobinuria (PNH) should be treated with eculizumab? ASH evidence-based review 2008Richard L Haspel, Peter Hillmen
Circulation. Cardiovascular Genetics|June 23, 2016
Improving Genomic Literacy Among Cardiovascular Practitioners via a Flipped-Classroom Workshop at a National MeetingKiran Musunuru, Richard L Haspel,
Transfusion|March 18, 2010
Prethaw predictors of cord blood unit qualityRichard L Haspel, Deborah Lamontagne
Transfusion|June 9, 2011
How do I audit hospital blood product utilization?Richard L Haspel, Lynne Uhl
Current Stem Cell Research & Therapy|December 17, 2008
Hematopoietic stem cells: source mattersRichard L Haspel, Kenneth B Miller
British Journal of Haematology|September 8, 2023
Major incompatible red blood cell transfusions prior to bone marrow transplantation: Not worth the riskRichard L Haspel, David H McKenna
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Archives of Pathology & Laboratory Medicine|July 1, 2010
Implementation and assessment of a resident curriculum in evidence-based transfusion medicineRichard L Haspel
Advances in Anatomic Pathology|February 13, 2013
Teaching residents genomic pathology: a novel approach for new technologyRichard L Haspel
Clinical Chemistry|July 7, 2020
Commentary on Sequence Now, Later, or Never?Richard L Haspel
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|March 24, 2005
The "cutting" edge: von Willebrand factor-cleaving protease activity in thrombotic microangiopathiesRichard L Haspel, Petr Jarolím
Hematology. American Society of Hematology. Education Program|December 17, 2008
Which patients with paroxysmal nocturnal hemoglobinuria (PNH) should be treated with eculizumab? ASH evidence-based review 2008Richard L Haspel, Peter Hillmen
Circulation. Cardiovascular Genetics|June 23, 2016
Improving Genomic Literacy Among Cardiovascular Practitioners via a Flipped-Classroom Workshop at a National MeetingKiran Musunuru, Richard L Haspel,
Transfusion|March 18, 2010
Prethaw predictors of cord blood unit qualityRichard L Haspel, Deborah Lamontagne
Transfusion|June 9, 2011
How do I audit hospital blood product utilization?Richard L Haspel, Lynne Uhl
Current Stem Cell Research & Therapy|December 17, 2008
Hematopoietic stem cells: source mattersRichard L Haspel, Kenneth B Miller
British Journal of Haematology|September 8, 2023
Major incompatible red blood cell transfusions prior to bone marrow transplantation: Not worth the riskRichard L Haspel, David H McKenna
Pageof 7